To further examine the effect of the PBRM1 mutation on the therapeutic sensitivity of PD1-1 antibody in colorectal tumor cells, we introduced humanized PD-1 mice (BALBc-hPD1). This evidence concerns the gene PDCD1 and colorectal neoplasm.